Beilstein J. Org. Chem.2012,8, 787–803, doi:10.3762/bjoc.8.89
as core structure were synthesized and screened in biological assays for their abilities to interfere in cell adhesion and other steps of the metastatic cascade, such as tumor-induced angiogenesis.
The most active compound, (4-{[(β-D-galactopyranosyl)oxy]methyl}furan-3-yl)methyl hydrogen sulfate (GSF
.
In an in vitro angiogenesis assay with human endothelial cells, GSF very effectively inhibited endothelial tubule formation and sprouting of blood vessels, as well as the adhesion of endothelial cells to ECM proteins. GSF was not cytotoxic at biologically active concentrations; neither were 3,4-bis
(hydroxymethyl)furan and benzoylated galactose imidate, is nontoxic and antagonizes cell physiological processes in vitro that are important for the dissemination and growth of tumor cells in vivo.
Keywords: angiogenesis; biomimetic synthesis; carbohydrates; in silico blind docking; melanoma cells
PDF
Graphical Abstract
Scheme 1:
Synthesis of (4-{[(β-D-galactopyranosyl)oxy]methyl}furan-3-yl)methyl hydrogen sulfate (GSF, 5) and ...
Beilstein J. Org. Chem.2011,7, 34–39, doi:10.3762/bjoc.7.6
% yield over six steps starting from D-phenylalanine and L-phenylalanine, respectively. The absolute configuration of the natural product was shown to be (4S,5S) by comparing its spectral and analytical data with the reported values.
Keywords: aldol reaction; angiogenesis; cancer; Lewis acid mediated
generally considerable associated toxicity, often with limited success. Therefore, more universal, more effective, and less toxic therapeutic agents are desirable. Recently, inhibition of angiogenesis has been considered as a desirable pathway for preventing tumor growth and metastasis, primarily because of
the low potential for toxicity or resistance [2], as well as the potential for treating a broad spectrum of tumor types, arthritis, and psoriasis [3][4][5][6][7][8]. For this reason, angiogenesis inhibition has become an active area of pharmaceutical research, and over 40 such agents are currently
PDF
Graphical Abstract
Figure 1:
Structures of (4R,5R)-streptopyrrolidine (1), (4S,5R)-streptopyrrolidine (2) (4R,5S)-streptopyrroli...